Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
State Street Corp's stake in Iovance Biotherapeutics, Inc. fell to 4.20% (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp's stake in Iovance Biotherapeutics, Inc. fell to 4.20%, 17,448,108 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 4.20%
- Shares
- 17,448,108
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 4.20% | 17,448,108 |
Source
Related
- Iovance Biotherapeutics, Inc.
- State Street Corp
- Iovance Biotherapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · State Street Corp · Feb 9, 2026
- Form 4 · Vogt Frederick G · Sep 10, 2026
- Form 4 · Bilinsky Igor · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 10, 2026
- Form 4 · Vogt Frederick G · Sep 3, 2026
- Form 4 · Puri Raj K. · Sep 3, 2026